Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Neuroinflammation in Chronic Back Pain
NCT03891264Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cannabidiol in chronic low back pain (CLBP), sponsored by Massachusetts General Hospital. Primary endpoint: Changes in Brain Positron Emission Tomography Signal at 4 weeks. Started Nov 2019; status: terminated.
02
Drugs
cannabidiol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT03891264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03891264.